nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—Alkylating Activity—Thiotepa—sarcoma	0.325	0.556	CiPCiCtD
Trabectedin—Alkylating Activity—Dacarbazine—sarcoma	0.26	0.444	CiPCiCtD
Trabectedin—SRC—sarcoma	0.242	1	CbGaD
Trabectedin—CYP2E1—Dacarbazine—sarcoma	0.0216	0.235	CbGbCtD
Trabectedin—CYP2E1—Mitoxantrone—sarcoma	0.0168	0.183	CbGbCtD
Trabectedin—PTGS1—Etoposide—sarcoma	0.0137	0.149	CbGbCtD
Trabectedin—CYP3A4—Thiotepa—sarcoma	0.0118	0.129	CbGbCtD
Trabectedin—CYP2E1—Etoposide—sarcoma	0.0106	0.115	CbGbCtD
Trabectedin—CYP3A4—Mitoxantrone—sarcoma	0.00509	0.0553	CbGbCtD
Trabectedin—CYP3A4—Vincristine—sarcoma	0.0035	0.0381	CbGbCtD
Trabectedin—CYP2D6—Doxorubicin—sarcoma	0.00344	0.0374	CbGbCtD
Trabectedin—CYP3A4—Etoposide—sarcoma	0.00321	0.0349	CbGbCtD
Trabectedin—CYP3A4—Doxorubicin—sarcoma	0.00219	0.0238	CbGbCtD
Trabectedin—SRC—periosteum—sarcoma	0.00162	0.23	CbGeAlD
Trabectedin—SRC—endothelium—sarcoma	0.000597	0.085	CbGeAlD
Trabectedin—SRC—embryo—sarcoma	0.000329	0.0467	CbGeAlD
Trabectedin—SRC—hematopoietic system—sarcoma	0.000293	0.0417	CbGeAlD
Trabectedin—SRC—connective tissue—sarcoma	0.000282	0.0402	CbGeAlD
Trabectedin—SRC—smooth muscle tissue—sarcoma	0.000258	0.0368	CbGeAlD
Trabectedin—SRC—skin of body—sarcoma	0.000255	0.0363	CbGeAlD
Trabectedin—PTGS1—endothelium—sarcoma	0.000223	0.0317	CbGeAlD
Trabectedin—SRC—cardiac atrium—sarcoma	0.000223	0.0317	CbGeAlD
Trabectedin—SRC—lymphoid tissue—sarcoma	0.000206	0.0294	CbGeAlD
Trabectedin—CYP2C9—mammary gland—sarcoma	0.000197	0.028	CbGeAlD
Trabectedin—SRC—testis—sarcoma	0.000161	0.0229	CbGeAlD
Trabectedin—CYP2C19—hematopoietic system—sarcoma	0.000155	0.022	CbGeAlD
Trabectedin—SRC—liver—sarcoma	0.000152	0.0216	CbGeAlD
Trabectedin—CYP2C9—hematopoietic system—sarcoma	0.00012	0.0171	CbGeAlD
Trabectedin—CYP2E1—seminal vesicle—sarcoma	0.00012	0.017	CbGeAlD
Trabectedin—SRC—lymph node—sarcoma	0.000116	0.0166	CbGeAlD
Trabectedin—PTGS1—seminal vesicle—sarcoma	0.000115	0.0164	CbGeAlD
Trabectedin—CYP2E1—hematopoietic system—sarcoma	0.000114	0.0162	CbGeAlD
Trabectedin—PTGS1—hematopoietic system—sarcoma	0.000109	0.0156	CbGeAlD
Trabectedin—PTGS1—connective tissue—sarcoma	0.000105	0.015	CbGeAlD
Trabectedin—PTGS1—smooth muscle tissue—sarcoma	9.64e-05	0.0137	CbGeAlD
Trabectedin—PTGS1—skin of body—sarcoma	9.52e-05	0.0135	CbGeAlD
Trabectedin—CYP3A4—hematopoietic system—sarcoma	9.14e-05	0.013	CbGeAlD
Trabectedin—CYP2D6—hematopoietic system—sarcoma	9e-05	0.0128	CbGeAlD
Trabectedin—Myalgia—Vincristine—sarcoma	8.58e-05	0.0018	CcSEcCtD
Trabectedin—Cough—Mitoxantrone—sarcoma	8.57e-05	0.0018	CcSEcCtD
Trabectedin—Angiopathy—Etoposide—sarcoma	8.51e-05	0.00179	CcSEcCtD
Trabectedin—Hepatic failure—Epirubicin—sarcoma	8.46e-05	0.00178	CcSEcCtD
Trabectedin—Mediastinal disorder—Etoposide—sarcoma	8.46e-05	0.00178	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Thiotepa—sarcoma	8.45e-05	0.00178	CcSEcCtD
Trabectedin—Sepsis—Doxorubicin—sarcoma	8.41e-05	0.00177	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Dactinomycin—sarcoma	8.39e-05	0.00176	CcSEcCtD
Trabectedin—Myalgia—Mitoxantrone—sarcoma	8.36e-05	0.00176	CcSEcCtD
Trabectedin—Arthralgia—Mitoxantrone—sarcoma	8.36e-05	0.00176	CcSEcCtD
Trabectedin—Paraesthesia—Thiotepa—sarcoma	8.33e-05	0.00175	CcSEcCtD
Trabectedin—PTGS1—cardiac atrium—sarcoma	8.31e-05	0.0118	CbGeAlD
Trabectedin—Alopecia—Etoposide—sarcoma	8.29e-05	0.00174	CcSEcCtD
Trabectedin—PTGS1—uterus—sarcoma	8.27e-05	0.0118	CbGeAlD
Trabectedin—Oedema—Vincristine—sarcoma	8.23e-05	0.00173	CcSEcCtD
Trabectedin—Infection—Vincristine—sarcoma	8.18e-05	0.00172	CcSEcCtD
Trabectedin—Dyspepsia—Thiotepa—sarcoma	8.17e-05	0.00172	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	8.09e-05	0.0017	CcSEcCtD
Trabectedin—Nervous system disorder—Vincristine—sarcoma	8.07e-05	0.00169	CcSEcCtD
Trabectedin—Decreased appetite—Thiotepa—sarcoma	8.07e-05	0.00169	CcSEcCtD
Trabectedin—Thrombocytopenia—Vincristine—sarcoma	8.06e-05	0.00169	CcSEcCtD
Trabectedin—Oedema—Mitoxantrone—sarcoma	8.01e-05	0.00168	CcSEcCtD
Trabectedin—CYP2C19—liver—sarcoma	8.01e-05	0.0114	CbGeAlD
Trabectedin—Gastrointestinal disorder—Thiotepa—sarcoma	8.01e-05	0.00168	CcSEcCtD
Trabectedin—Decreased appetite—Dactinomycin—sarcoma	8.01e-05	0.00168	CcSEcCtD
Trabectedin—Fatigue—Thiotepa—sarcoma	8e-05	0.00168	CcSEcCtD
Trabectedin—CYP2E1—lymphoid tissue—sarcoma	8e-05	0.0114	CbGeAlD
Trabectedin—Dysgeusia—Etoposide—sarcoma	8e-05	0.00168	CcSEcCtD
Trabectedin—Infection—Mitoxantrone—sarcoma	7.96e-05	0.00167	CcSEcCtD
Trabectedin—Fatigue—Dactinomycin—sarcoma	7.94e-05	0.00167	CcSEcCtD
Trabectedin—Constipation—Thiotepa—sarcoma	7.94e-05	0.00167	CcSEcCtD
Trabectedin—Back pain—Etoposide—sarcoma	7.9e-05	0.00166	CcSEcCtD
Trabectedin—Shock—Mitoxantrone—sarcoma	7.88e-05	0.00166	CcSEcCtD
Trabectedin—Thrombocytopenia—Mitoxantrone—sarcoma	7.85e-05	0.00165	CcSEcCtD
Trabectedin—Anorexia—Vincristine—sarcoma	7.84e-05	0.00165	CcSEcCtD
Trabectedin—Hepatic failure—Doxorubicin—sarcoma	7.83e-05	0.00164	CcSEcCtD
Trabectedin—Skin disorder—Mitoxantrone—sarcoma	7.78e-05	0.00163	CcSEcCtD
Trabectedin—Hypotension—Vincristine—sarcoma	7.69e-05	0.00161	CcSEcCtD
Trabectedin—Anorexia—Mitoxantrone—sarcoma	7.64e-05	0.0016	CcSEcCtD
Trabectedin—Gastrointestinal pain—Thiotepa—sarcoma	7.59e-05	0.00159	CcSEcCtD
Trabectedin—Anaemia—Etoposide—sarcoma	7.55e-05	0.00159	CcSEcCtD
Trabectedin—Gastrointestinal pain—Dactinomycin—sarcoma	7.53e-05	0.00158	CcSEcCtD
Trabectedin—CYP2E1—tendon—sarcoma	7.52e-05	0.0107	CbGeAlD
Trabectedin—Musculoskeletal discomfort—Vincristine—sarcoma	7.5e-05	0.00157	CcSEcCtD
Trabectedin—Hypotension—Mitoxantrone—sarcoma	7.49e-05	0.00157	CcSEcCtD
Trabectedin—Insomnia—Vincristine—sarcoma	7.44e-05	0.00156	CcSEcCtD
Trabectedin—Paraesthesia—Vincristine—sarcoma	7.39e-05	0.00155	CcSEcCtD
Trabectedin—Abdominal pain—Thiotepa—sarcoma	7.34e-05	0.00154	CcSEcCtD
Trabectedin—Body temperature increased—Thiotepa—sarcoma	7.34e-05	0.00154	CcSEcCtD
Trabectedin—Leukopenia—Etoposide—sarcoma	7.31e-05	0.00154	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	7.3e-05	0.00153	CcSEcCtD
Trabectedin—Abdominal pain—Dactinomycin—sarcoma	7.28e-05	0.00153	CcSEcCtD
Trabectedin—Body temperature increased—Dactinomycin—sarcoma	7.28e-05	0.00153	CcSEcCtD
Trabectedin—PTGS1—tendon—sarcoma	7.24e-05	0.0103	CbGeAlD
Trabectedin—Paraesthesia—Mitoxantrone—sarcoma	7.2e-05	0.00151	CcSEcCtD
Trabectedin—Loss of consciousness—Etoposide—sarcoma	7.18e-05	0.00151	CcSEcCtD
Trabectedin—Decreased appetite—Vincristine—sarcoma	7.15e-05	0.0015	CcSEcCtD
Trabectedin—Dyspnoea—Mitoxantrone—sarcoma	7.14e-05	0.0015	CcSEcCtD
Trabectedin—Cough—Etoposide—sarcoma	7.13e-05	0.0015	CcSEcCtD
Trabectedin—Blood creatinine increased—Epirubicin—sarcoma	7.12e-05	0.0015	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Vincristine—sarcoma	7.1e-05	0.00149	CcSEcCtD
Trabectedin—Fatigue—Vincristine—sarcoma	7.09e-05	0.00149	CcSEcCtD
Trabectedin—Dehydration—Epirubicin—sarcoma	7.07e-05	0.00148	CcSEcCtD
Trabectedin—Dyspepsia—Mitoxantrone—sarcoma	7.05e-05	0.00148	CcSEcCtD
Trabectedin—Constipation—Vincristine—sarcoma	7.04e-05	0.00148	CcSEcCtD
Trabectedin—Decreased appetite—Mitoxantrone—sarcoma	6.97e-05	0.00146	CcSEcCtD
Trabectedin—Abdominal pain upper—Epirubicin—sarcoma	6.94e-05	0.00146	CcSEcCtD
Trabectedin—Hypokalaemia—Epirubicin—sarcoma	6.92e-05	0.00145	CcSEcCtD
Trabectedin—Fatigue—Mitoxantrone—sarcoma	6.91e-05	0.00145	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	6.91e-05	0.00145	CcSEcCtD
Trabectedin—Constipation—Mitoxantrone—sarcoma	6.85e-05	0.00144	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Epirubicin—sarcoma	6.85e-05	0.00144	CcSEcCtD
Trabectedin—Hypersensitivity—Thiotepa—sarcoma	6.84e-05	0.00144	CcSEcCtD
Trabectedin—Hypersensitivity—Dactinomycin—sarcoma	6.79e-05	0.00143	CcSEcCtD
Trabectedin—Gastrointestinal pain—Vincristine—sarcoma	6.73e-05	0.00141	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Epirubicin—sarcoma	6.71e-05	0.00141	CcSEcCtD
Trabectedin—Asthenia—Thiotepa—sarcoma	6.66e-05	0.0014	CcSEcCtD
Trabectedin—Infection—Etoposide—sarcoma	6.62e-05	0.00139	CcSEcCtD
Trabectedin—Asthenia—Dactinomycin—sarcoma	6.61e-05	0.00139	CcSEcCtD
Trabectedin—Blood creatinine increased—Doxorubicin—sarcoma	6.59e-05	0.00138	CcSEcCtD
Trabectedin—Gastrointestinal pain—Mitoxantrone—sarcoma	6.55e-05	0.00138	CcSEcCtD
Trabectedin—Dehydration—Doxorubicin—sarcoma	6.54e-05	0.00137	CcSEcCtD
Trabectedin—Thrombocytopenia—Etoposide—sarcoma	6.53e-05	0.00137	CcSEcCtD
Trabectedin—Body temperature increased—Vincristine—sarcoma	6.51e-05	0.00137	CcSEcCtD
Trabectedin—Abdominal pain—Vincristine—sarcoma	6.51e-05	0.00137	CcSEcCtD
Trabectedin—Skin disorder—Etoposide—sarcoma	6.47e-05	0.00136	CcSEcCtD
Trabectedin—Abdominal pain upper—Doxorubicin—sarcoma	6.42e-05	0.00135	CcSEcCtD
Trabectedin—Hypokalaemia—Doxorubicin—sarcoma	6.4e-05	0.00134	CcSEcCtD
Trabectedin—Anorexia—Etoposide—sarcoma	6.35e-05	0.00133	CcSEcCtD
Trabectedin—Diarrhoea—Thiotepa—sarcoma	6.35e-05	0.00133	CcSEcCtD
Trabectedin—Body temperature increased—Mitoxantrone—sarcoma	6.34e-05	0.00133	CcSEcCtD
Trabectedin—Abdominal pain—Mitoxantrone—sarcoma	6.34e-05	0.00133	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Doxorubicin—sarcoma	6.33e-05	0.00133	CcSEcCtD
Trabectedin—Diarrhoea—Dactinomycin—sarcoma	6.3e-05	0.00132	CcSEcCtD
Trabectedin—Pancytopenia—Epirubicin—sarcoma	6.24e-05	0.00131	CcSEcCtD
Trabectedin—Hypotension—Etoposide—sarcoma	6.23e-05	0.00131	CcSEcCtD
Trabectedin—CYP2E1—testis—sarcoma	6.23e-05	0.00886	CbGeAlD
Trabectedin—CYP2C9—liver—sarcoma	6.21e-05	0.00884	CbGeAlD
Trabectedin—Alanine aminotransferase increased—Doxorubicin—sarcoma	6.2e-05	0.0013	CcSEcCtD
Trabectedin—Neutropenia—Epirubicin—sarcoma	6.14e-05	0.00129	CcSEcCtD
Trabectedin—Dizziness—Thiotepa—sarcoma	6.14e-05	0.00129	CcSEcCtD
Trabectedin—Hypersensitivity—Vincristine—sarcoma	6.06e-05	0.00127	CcSEcCtD
Trabectedin—PTGS1—testis—sarcoma	6e-05	0.00853	CbGeAlD
Trabectedin—Paraesthesia—Etoposide—sarcoma	5.99e-05	0.00126	CcSEcCtD
Trabectedin—Weight decreased—Epirubicin—sarcoma	5.94e-05	0.00125	CcSEcCtD
Trabectedin—Dyspnoea—Etoposide—sarcoma	5.94e-05	0.00125	CcSEcCtD
Trabectedin—Hypersensitivity—Mitoxantrone—sarcoma	5.9e-05	0.00124	CcSEcCtD
Trabectedin—Asthenia—Vincristine—sarcoma	5.9e-05	0.00124	CcSEcCtD
Trabectedin—Vomiting—Thiotepa—sarcoma	5.9e-05	0.00124	CcSEcCtD
Trabectedin—CYP2E1—liver—sarcoma	5.89e-05	0.00838	CbGeAlD
Trabectedin—Infestation—Epirubicin—sarcoma	5.86e-05	0.00123	CcSEcCtD
Trabectedin—Infestation NOS—Epirubicin—sarcoma	5.86e-05	0.00123	CcSEcCtD
Trabectedin—Vomiting—Dactinomycin—sarcoma	5.86e-05	0.00123	CcSEcCtD
Trabectedin—Rash—Thiotepa—sarcoma	5.85e-05	0.00123	CcSEcCtD
Trabectedin—Dermatitis—Thiotepa—sarcoma	5.85e-05	0.00123	CcSEcCtD
Trabectedin—Headache—Thiotepa—sarcoma	5.81e-05	0.00122	CcSEcCtD
Trabectedin—Rash—Dactinomycin—sarcoma	5.81e-05	0.00122	CcSEcCtD
Trabectedin—Decreased appetite—Etoposide—sarcoma	5.79e-05	0.00122	CcSEcCtD
Trabectedin—Pancytopenia—Doxorubicin—sarcoma	5.77e-05	0.00121	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Etoposide—sarcoma	5.76e-05	0.00121	CcSEcCtD
Trabectedin—Asthenia—Mitoxantrone—sarcoma	5.75e-05	0.00121	CcSEcCtD
Trabectedin—Fatigue—Etoposide—sarcoma	5.75e-05	0.00121	CcSEcCtD
Trabectedin—Stomatitis—Epirubicin—sarcoma	5.71e-05	0.0012	CcSEcCtD
Trabectedin—Jaundice—Epirubicin—sarcoma	5.71e-05	0.0012	CcSEcCtD
Trabectedin—Constipation—Etoposide—sarcoma	5.7e-05	0.0012	CcSEcCtD
Trabectedin—Neutropenia—Doxorubicin—sarcoma	5.69e-05	0.00119	CcSEcCtD
Trabectedin—Diarrhoea—Vincristine—sarcoma	5.63e-05	0.00118	CcSEcCtD
Trabectedin—Hepatobiliary disease—Epirubicin—sarcoma	5.54e-05	0.00116	CcSEcCtD
Trabectedin—Nausea—Thiotepa—sarcoma	5.51e-05	0.00116	CcSEcCtD
Trabectedin—Weight decreased—Doxorubicin—sarcoma	5.5e-05	0.00116	CcSEcCtD
Trabectedin—Diarrhoea—Mitoxantrone—sarcoma	5.48e-05	0.00115	CcSEcCtD
Trabectedin—Nausea—Dactinomycin—sarcoma	5.47e-05	0.00115	CcSEcCtD
Trabectedin—Agranulocytosis—Epirubicin—sarcoma	5.47e-05	0.00115	CcSEcCtD
Trabectedin—Gastrointestinal pain—Etoposide—sarcoma	5.45e-05	0.00114	CcSEcCtD
Trabectedin—Dizziness—Vincristine—sarcoma	5.44e-05	0.00114	CcSEcCtD
Trabectedin—Infestation NOS—Doxorubicin—sarcoma	5.42e-05	0.00114	CcSEcCtD
Trabectedin—Infestation—Doxorubicin—sarcoma	5.42e-05	0.00114	CcSEcCtD
Trabectedin—Haemoglobin—Epirubicin—sarcoma	5.29e-05	0.00111	CcSEcCtD
Trabectedin—Jaundice—Doxorubicin—sarcoma	5.28e-05	0.00111	CcSEcCtD
Trabectedin—Stomatitis—Doxorubicin—sarcoma	5.28e-05	0.00111	CcSEcCtD
Trabectedin—Body temperature increased—Etoposide—sarcoma	5.27e-05	0.00111	CcSEcCtD
Trabectedin—Abdominal pain—Etoposide—sarcoma	5.27e-05	0.00111	CcSEcCtD
Trabectedin—Haemorrhage—Epirubicin—sarcoma	5.26e-05	0.0011	CcSEcCtD
Trabectedin—Vomiting—Vincristine—sarcoma	5.23e-05	0.0011	CcSEcCtD
Trabectedin—Rash—Vincristine—sarcoma	5.19e-05	0.00109	CcSEcCtD
Trabectedin—Dermatitis—Vincristine—sarcoma	5.18e-05	0.00109	CcSEcCtD
Trabectedin—Oedema peripheral—Epirubicin—sarcoma	5.18e-05	0.00109	CcSEcCtD
Trabectedin—Connective tissue disorder—Epirubicin—sarcoma	5.17e-05	0.00109	CcSEcCtD
Trabectedin—Headache—Vincristine—sarcoma	5.16e-05	0.00108	CcSEcCtD
Trabectedin—Hepatobiliary disease—Doxorubicin—sarcoma	5.13e-05	0.00108	CcSEcCtD
Trabectedin—Vomiting—Mitoxantrone—sarcoma	5.1e-05	0.00107	CcSEcCtD
Trabectedin—Agranulocytosis—Doxorubicin—sarcoma	5.06e-05	0.00106	CcSEcCtD
Trabectedin—Rash—Mitoxantrone—sarcoma	5.05e-05	0.00106	CcSEcCtD
Trabectedin—Dermatitis—Mitoxantrone—sarcoma	5.05e-05	0.00106	CcSEcCtD
Trabectedin—Headache—Mitoxantrone—sarcoma	5.02e-05	0.00105	CcSEcCtD
Trabectedin—CYP2D6—testis—sarcoma	4.93e-05	0.00702	CbGeAlD
Trabectedin—Hypersensitivity—Etoposide—sarcoma	4.91e-05	0.00103	CcSEcCtD
Trabectedin—Haemoglobin—Doxorubicin—sarcoma	4.89e-05	0.00103	CcSEcCtD
Trabectedin—Nausea—Vincristine—sarcoma	4.89e-05	0.00103	CcSEcCtD
Trabectedin—Flushing—Epirubicin—sarcoma	4.88e-05	0.00103	CcSEcCtD
Trabectedin—Haemorrhage—Doxorubicin—sarcoma	4.87e-05	0.00102	CcSEcCtD
Trabectedin—Oedema peripheral—Doxorubicin—sarcoma	4.79e-05	0.00101	CcSEcCtD
Trabectedin—Asthenia—Etoposide—sarcoma	4.78e-05	0.001	CcSEcCtD
Trabectedin—Connective tissue disorder—Doxorubicin—sarcoma	4.78e-05	0.001	CcSEcCtD
Trabectedin—Angiopathy—Epirubicin—sarcoma	4.77e-05	0.001	CcSEcCtD
Trabectedin—Nausea—Mitoxantrone—sarcoma	4.76e-05	0.001	CcSEcCtD
Trabectedin—Mediastinal disorder—Epirubicin—sarcoma	4.74e-05	0.000996	CcSEcCtD
Trabectedin—CYP3A4—liver—sarcoma	4.74e-05	0.00674	CbGeAlD
Trabectedin—CYP2D6—liver—sarcoma	4.66e-05	0.00663	CbGeAlD
Trabectedin—Alopecia—Epirubicin—sarcoma	4.65e-05	0.000976	CcSEcCtD
Trabectedin—Mental disorder—Epirubicin—sarcoma	4.61e-05	0.000968	CcSEcCtD
Trabectedin—Malnutrition—Epirubicin—sarcoma	4.58e-05	0.000962	CcSEcCtD
Trabectedin—Diarrhoea—Etoposide—sarcoma	4.56e-05	0.000958	CcSEcCtD
Trabectedin—Flushing—Doxorubicin—sarcoma	4.52e-05	0.000949	CcSEcCtD
Trabectedin—Dysgeusia—Epirubicin—sarcoma	4.48e-05	0.000942	CcSEcCtD
Trabectedin—Back pain—Epirubicin—sarcoma	4.43e-05	0.00093	CcSEcCtD
Trabectedin—Angiopathy—Doxorubicin—sarcoma	4.42e-05	0.000927	CcSEcCtD
Trabectedin—Dizziness—Etoposide—sarcoma	4.41e-05	0.000926	CcSEcCtD
Trabectedin—Mediastinal disorder—Doxorubicin—sarcoma	4.39e-05	0.000921	CcSEcCtD
Trabectedin—PTGS1—lymph node—sarcoma	4.35e-05	0.00619	CbGeAlD
Trabectedin—Alopecia—Doxorubicin—sarcoma	4.3e-05	0.000903	CcSEcCtD
Trabectedin—Mental disorder—Doxorubicin—sarcoma	4.26e-05	0.000895	CcSEcCtD
Trabectedin—Vomiting—Etoposide—sarcoma	4.24e-05	0.00089	CcSEcCtD
Trabectedin—Malnutrition—Doxorubicin—sarcoma	4.24e-05	0.00089	CcSEcCtD
Trabectedin—Anaemia—Epirubicin—sarcoma	4.23e-05	0.000889	CcSEcCtD
Trabectedin—Rash—Etoposide—sarcoma	4.2e-05	0.000883	CcSEcCtD
Trabectedin—Dermatitis—Etoposide—sarcoma	4.2e-05	0.000882	CcSEcCtD
Trabectedin—Headache—Etoposide—sarcoma	4.18e-05	0.000877	CcSEcCtD
Trabectedin—Dysgeusia—Doxorubicin—sarcoma	4.15e-05	0.000871	CcSEcCtD
Trabectedin—Syncope—Epirubicin—sarcoma	4.11e-05	0.000862	CcSEcCtD
Trabectedin—Leukopenia—Epirubicin—sarcoma	4.1e-05	0.000861	CcSEcCtD
Trabectedin—Back pain—Doxorubicin—sarcoma	4.1e-05	0.000861	CcSEcCtD
Trabectedin—Loss of consciousness—Epirubicin—sarcoma	4.02e-05	0.000845	CcSEcCtD
Trabectedin—Cough—Epirubicin—sarcoma	4e-05	0.000839	CcSEcCtD
Trabectedin—Nausea—Etoposide—sarcoma	3.96e-05	0.000832	CcSEcCtD
Trabectedin—Anaemia—Doxorubicin—sarcoma	3.92e-05	0.000822	CcSEcCtD
Trabectedin—Myalgia—Epirubicin—sarcoma	3.9e-05	0.000819	CcSEcCtD
Trabectedin—Arthralgia—Epirubicin—sarcoma	3.9e-05	0.000819	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	3.87e-05	0.000813	CcSEcCtD
Trabectedin—Syncope—Doxorubicin—sarcoma	3.8e-05	0.000798	CcSEcCtD
Trabectedin—Leukopenia—Doxorubicin—sarcoma	3.79e-05	0.000796	CcSEcCtD
Trabectedin—Oedema—Epirubicin—sarcoma	3.74e-05	0.000785	CcSEcCtD
Trabectedin—Loss of consciousness—Doxorubicin—sarcoma	3.72e-05	0.000782	CcSEcCtD
Trabectedin—Infection—Epirubicin—sarcoma	3.71e-05	0.00078	CcSEcCtD
Trabectedin—Cough—Doxorubicin—sarcoma	3.7e-05	0.000776	CcSEcCtD
Trabectedin—Shock—Epirubicin—sarcoma	3.68e-05	0.000772	CcSEcCtD
Trabectedin—Nervous system disorder—Epirubicin—sarcoma	3.66e-05	0.00077	CcSEcCtD
Trabectedin—Thrombocytopenia—Epirubicin—sarcoma	3.66e-05	0.000768	CcSEcCtD
Trabectedin—Skin disorder—Epirubicin—sarcoma	3.63e-05	0.000762	CcSEcCtD
Trabectedin—Arthralgia—Doxorubicin—sarcoma	3.61e-05	0.000757	CcSEcCtD
Trabectedin—Myalgia—Doxorubicin—sarcoma	3.61e-05	0.000757	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	3.58e-05	0.000752	CcSEcCtD
Trabectedin—Anorexia—Epirubicin—sarcoma	3.56e-05	0.000748	CcSEcCtD
Trabectedin—Hypotension—Epirubicin—sarcoma	3.49e-05	0.000733	CcSEcCtD
Trabectedin—Oedema—Doxorubicin—sarcoma	3.46e-05	0.000726	CcSEcCtD
Trabectedin—Infection—Doxorubicin—sarcoma	3.43e-05	0.000721	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Epirubicin—sarcoma	3.4e-05	0.000715	CcSEcCtD
Trabectedin—Shock—Doxorubicin—sarcoma	3.4e-05	0.000714	CcSEcCtD
Trabectedin—Nervous system disorder—Doxorubicin—sarcoma	3.39e-05	0.000712	CcSEcCtD
Trabectedin—Thrombocytopenia—Doxorubicin—sarcoma	3.39e-05	0.000711	CcSEcCtD
Trabectedin—Insomnia—Epirubicin—sarcoma	3.38e-05	0.00071	CcSEcCtD
Trabectedin—Skin disorder—Doxorubicin—sarcoma	3.36e-05	0.000705	CcSEcCtD
Trabectedin—Paraesthesia—Epirubicin—sarcoma	3.36e-05	0.000705	CcSEcCtD
Trabectedin—Dyspnoea—Epirubicin—sarcoma	3.33e-05	0.0007	CcSEcCtD
Trabectedin—Anorexia—Doxorubicin—sarcoma	3.3e-05	0.000692	CcSEcCtD
Trabectedin—Dyspepsia—Epirubicin—sarcoma	3.29e-05	0.000691	CcSEcCtD
Trabectedin—Decreased appetite—Epirubicin—sarcoma	3.25e-05	0.000682	CcSEcCtD
Trabectedin—Hypotension—Doxorubicin—sarcoma	3.23e-05	0.000679	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Epirubicin—sarcoma	3.23e-05	0.000678	CcSEcCtD
Trabectedin—Fatigue—Epirubicin—sarcoma	3.22e-05	0.000677	CcSEcCtD
Trabectedin—Constipation—Epirubicin—sarcoma	3.2e-05	0.000671	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Doxorubicin—sarcoma	3.15e-05	0.000662	CcSEcCtD
Trabectedin—Insomnia—Doxorubicin—sarcoma	3.13e-05	0.000657	CcSEcCtD
Trabectedin—Paraesthesia—Doxorubicin—sarcoma	3.1e-05	0.000652	CcSEcCtD
Trabectedin—Dyspnoea—Doxorubicin—sarcoma	3.08e-05	0.000647	CcSEcCtD
Trabectedin—Gastrointestinal pain—Epirubicin—sarcoma	3.06e-05	0.000642	CcSEcCtD
Trabectedin—Dyspepsia—Doxorubicin—sarcoma	3.04e-05	0.000639	CcSEcCtD
Trabectedin—Decreased appetite—Doxorubicin—sarcoma	3.01e-05	0.000631	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Doxorubicin—sarcoma	2.98e-05	0.000627	CcSEcCtD
Trabectedin—Fatigue—Doxorubicin—sarcoma	2.98e-05	0.000626	CcSEcCtD
Trabectedin—Constipation—Doxorubicin—sarcoma	2.96e-05	0.000621	CcSEcCtD
Trabectedin—Body temperature increased—Epirubicin—sarcoma	2.95e-05	0.00062	CcSEcCtD
Trabectedin—Abdominal pain—Epirubicin—sarcoma	2.95e-05	0.00062	CcSEcCtD
Trabectedin—Gastrointestinal pain—Doxorubicin—sarcoma	2.83e-05	0.000594	CcSEcCtD
Trabectedin—Hypersensitivity—Epirubicin—sarcoma	2.75e-05	0.000578	CcSEcCtD
Trabectedin—Body temperature increased—Doxorubicin—sarcoma	2.73e-05	0.000574	CcSEcCtD
Trabectedin—Abdominal pain—Doxorubicin—sarcoma	2.73e-05	0.000574	CcSEcCtD
Trabectedin—Asthenia—Epirubicin—sarcoma	2.68e-05	0.000563	CcSEcCtD
Trabectedin—Diarrhoea—Epirubicin—sarcoma	2.56e-05	0.000537	CcSEcCtD
Trabectedin—Hypersensitivity—Doxorubicin—sarcoma	2.55e-05	0.000535	CcSEcCtD
Trabectedin—Asthenia—Doxorubicin—sarcoma	2.48e-05	0.000521	CcSEcCtD
Trabectedin—Dizziness—Epirubicin—sarcoma	2.47e-05	0.000519	CcSEcCtD
Trabectedin—SRC—Androgen receptor signaling pathway—EGFR—sarcoma	2.41e-05	0.000887	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—CREB1—sarcoma	2.41e-05	0.000885	CbGpPWpGaD
Trabectedin—SRC—NCAM signaling for neurite out-growth—HRAS—sarcoma	2.4e-05	0.000883	CbGpPWpGaD
Trabectedin—Vomiting—Epirubicin—sarcoma	2.38e-05	0.000499	CcSEcCtD
Trabectedin—Diarrhoea—Doxorubicin—sarcoma	2.37e-05	0.000497	CcSEcCtD
Trabectedin—Rash—Epirubicin—sarcoma	2.36e-05	0.000495	CcSEcCtD
Trabectedin—Dermatitis—Epirubicin—sarcoma	2.35e-05	0.000494	CcSEcCtD
Trabectedin—SRC—CDC42 signaling events—HRAS—sarcoma	2.35e-05	0.000863	CbGpPWpGaD
Trabectedin—Headache—Epirubicin—sarcoma	2.34e-05	0.000492	CcSEcCtD
Trabectedin—SRC—PDGFR-beta signaling pathway—JUN—sarcoma	2.34e-05	0.000859	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—NRAS—sarcoma	2.32e-05	0.000853	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.32e-05	0.000851	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—VEGFA—sarcoma	2.31e-05	0.00085	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—FOXO1—sarcoma	2.31e-05	0.00085	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PDGFRB—sarcoma	2.31e-05	0.000848	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—KIT—sarcoma	2.29e-05	0.000842	CbGpPWpGaD
Trabectedin—Dizziness—Doxorubicin—sarcoma	2.29e-05	0.00048	CcSEcCtD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—NRAS—sarcoma	2.28e-05	0.00084	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PDGFRA—sarcoma	2.27e-05	0.000835	CbGpPWpGaD
Trabectedin—SRC—L1CAM interactions—EGFR—sarcoma	2.27e-05	0.000835	CbGpPWpGaD
Trabectedin—SRC—Cell-Cell communication—CTNNB1—sarcoma	2.25e-05	0.000827	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—CCND1—sarcoma	2.24e-05	0.000824	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—JUN—sarcoma	2.24e-05	0.000823	CbGpPWpGaD
Trabectedin—SRC—Leptin signaling pathway—HRAS—sarcoma	2.22e-05	0.000816	CbGpPWpGaD
Trabectedin—Nausea—Epirubicin—sarcoma	2.22e-05	0.000466	CcSEcCtD
Trabectedin—Vomiting—Doxorubicin—sarcoma	2.2e-05	0.000462	CcSEcCtD
Trabectedin—SRC—Downstream signal transduction—MDM2—sarcoma	2.2e-05	0.000808	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—MDM2—sarcoma	2.19e-05	0.000804	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—VEGFA—sarcoma	2.18e-05	0.000803	CbGpPWpGaD
Trabectedin—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	2.18e-05	0.000802	CbGpPWpGaD
Trabectedin—Rash—Doxorubicin—sarcoma	2.18e-05	0.000458	CcSEcCtD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—CREB1—sarcoma	2.18e-05	0.000801	CbGpPWpGaD
Trabectedin—Dermatitis—Doxorubicin—sarcoma	2.18e-05	0.000457	CcSEcCtD
Trabectedin—SRC—Signaling by ERBB2—MDM2—sarcoma	2.17e-05	0.0008	CbGpPWpGaD
Trabectedin—Headache—Doxorubicin—sarcoma	2.17e-05	0.000455	CcSEcCtD
Trabectedin—SRC—GAB1 signalosome—EGFR—sarcoma	2.16e-05	0.000795	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—TP53—sarcoma	2.16e-05	0.000795	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—NRAS—sarcoma	2.16e-05	0.000793	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—PTPRC—sarcoma	2.15e-05	0.00079	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—EGFR—sarcoma	2.11e-05	0.000777	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—sarcoma	2.11e-05	0.000775	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—PLCG1—sarcoma	2.1e-05	0.000773	CbGpPWpGaD
Trabectedin—SRC—Cell surface interactions at the vascular wall—KRAS—sarcoma	2.09e-05	0.000769	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—JUN—sarcoma	2.09e-05	0.000767	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—CTNNB1—sarcoma	2.07e-05	0.000762	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—HRAS—sarcoma	2.07e-05	0.00076	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PLCG1—sarcoma	2.06e-05	0.000759	CbGpPWpGaD
Trabectedin—Nausea—Doxorubicin—sarcoma	2.05e-05	0.000431	CcSEcCtD
Trabectedin—SRC—Signaling by FGFR in disease—MDM2—sarcoma	2.04e-05	0.000749	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—MDM2—sarcoma	2.02e-05	0.000742	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—NRAS—sarcoma	2.02e-05	0.000742	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—MDM2—sarcoma	2e-05	0.000735	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—KRAS—sarcoma	2e-05	0.000734	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—MDM2—sarcoma	1.99e-05	0.000732	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—KRAS—sarcoma	1.97e-05	0.000723	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.92e-05	0.000704	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—JUN—sarcoma	1.9e-05	0.000698	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—MYC—sarcoma	1.88e-05	0.000691	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PLCG1—sarcoma	1.86e-05	0.000683	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—KRAS—sarcoma	1.86e-05	0.000682	CbGpPWpGaD
Trabectedin—SRC—EPH-Ephrin signaling—HRAS—sarcoma	1.85e-05	0.000682	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—NRAS—sarcoma	1.83e-05	0.000673	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PTPRC—sarcoma	1.82e-05	0.00067	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—MDM2—sarcoma	1.8e-05	0.000663	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—MYC—sarcoma	1.8e-05	0.000661	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PLCG1—sarcoma	1.78e-05	0.000656	CbGpPWpGaD
Trabectedin—SRC—Cell surface interactions at the vascular wall—HRAS—sarcoma	1.78e-05	0.000654	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TP53—sarcoma	1.77e-05	0.000652	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—ATF1—sarcoma	1.76e-05	0.000649	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—HRAS—sarcoma	1.76e-05	0.000649	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—KIT—sarcoma	1.76e-05	0.000647	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—KRAS—sarcoma	1.74e-05	0.000638	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—KDR—sarcoma	1.73e-05	0.000636	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—HRAS—sarcoma	1.7e-05	0.000624	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—HRAS—sarcoma	1.7e-05	0.000624	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—CREB1—sarcoma	1.68e-05	0.000616	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—CCND1—sarcoma	1.68e-05	0.000616	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—JUN—sarcoma	1.67e-05	0.000615	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—HRAS—sarcoma	1.67e-05	0.000614	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—EGFR—sarcoma	1.67e-05	0.000614	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.67e-05	0.000614	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.66e-05	0.000612	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—CTNNB1—sarcoma	1.66e-05	0.00061	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.65e-05	0.000608	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—NRAS—sarcoma	1.65e-05	0.000606	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—NRAS—sarcoma	1.64e-05	0.000603	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—NRAS—sarcoma	1.63e-05	0.0006	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—HRAS—sarcoma	1.58e-05	0.00058	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—KRAS—sarcoma	1.58e-05	0.00058	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD34—sarcoma	1.53e-05	0.000562	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—NRAS—sarcoma	1.53e-05	0.000561	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—IL2—sarcoma	1.52e-05	0.00056	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—CREB1—sarcoma	1.52e-05	0.000558	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—NRAS—sarcoma	1.51e-05	0.000556	CbGpPWpGaD
Trabectedin—SRC—Disease—TLE1—sarcoma	1.51e-05	0.000554	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—EGFR—sarcoma	1.5e-05	0.000552	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—NRAS—sarcoma	1.5e-05	0.000552	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—EGFR—sarcoma	1.49e-05	0.000549	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—EGFR—sarcoma	1.49e-05	0.000549	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—NRAS—sarcoma	1.49e-05	0.000549	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—FOXO1—sarcoma	1.49e-05	0.000549	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—EGFR—sarcoma	1.49e-05	0.000546	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TP53—sarcoma	1.48e-05	0.000543	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—HRAS—sarcoma	1.48e-05	0.000543	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—VEGFA—sarcoma	1.46e-05	0.000537	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.45e-05	0.000535	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—KRAS—sarcoma	1.42e-05	0.000521	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MMP2—sarcoma	1.41e-05	0.000519	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—KRAS—sarcoma	1.41e-05	0.000519	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—KRAS—sarcoma	1.41e-05	0.000519	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—KRAS—sarcoma	1.4e-05	0.000516	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—EGFR—sarcoma	1.39e-05	0.000512	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—MDM2—sarcoma	1.39e-05	0.00051	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—EGFR—sarcoma	1.38e-05	0.000507	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—EGFR—sarcoma	1.37e-05	0.000502	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—EGFR—sarcoma	1.36e-05	0.0005	CbGpPWpGaD
Trabectedin—SRC—Disease—NPM1—sarcoma	1.36e-05	0.0005	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—NRAS—sarcoma	1.35e-05	0.000497	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—HRAS—sarcoma	1.34e-05	0.000493	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.34e-05	0.000492	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—FOXO1—sarcoma	1.32e-05	0.000485	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—HRAS—sarcoma	1.32e-05	0.000484	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PDGFRB—sarcoma	1.32e-05	0.000484	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—EGFR—sarcoma	1.31e-05	0.000483	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—KRAS—sarcoma	1.31e-05	0.000483	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.31e-05	0.000481	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—KRAS—sarcoma	1.3e-05	0.000479	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PDGFRA—sarcoma	1.3e-05	0.000476	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—VEGFA—sarcoma	1.29e-05	0.000476	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—KRAS—sarcoma	1.29e-05	0.000475	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—KRAS—sarcoma	1.29e-05	0.000473	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—FOXO1—sarcoma	1.27e-05	0.000465	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PDGFRB—sarcoma	1.26e-05	0.000465	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PDGFRA—sarcoma	1.24e-05	0.000457	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.24e-05	0.000455	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—KDR—sarcoma	1.23e-05	0.000454	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—EGFR—sarcoma	1.23e-05	0.000453	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—HRAS—sarcoma	1.21e-05	0.000443	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—HRAS—sarcoma	1.2e-05	0.000441	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—HRAS—sarcoma	1.2e-05	0.000441	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—HRAS—sarcoma	1.19e-05	0.000439	CbGpPWpGaD
Trabectedin—SRC—Disease—ENO2—sarcoma	1.18e-05	0.000433	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	1.16e-05	0.000428	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—HRAS—sarcoma	1.12e-05	0.000411	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—HRAS—sarcoma	1.11e-05	0.000407	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTPRC—sarcoma	1.11e-05	0.000407	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.1e-05	0.000404	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—HRAS—sarcoma	1.1e-05	0.000403	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—HRAS—sarcoma	1.09e-05	0.000402	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CREB1—sarcoma	1.08e-05	0.000398	CbGpPWpGaD
Trabectedin—SRC—Immune System—PLCG1—sarcoma	1.08e-05	0.000398	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—HRAS—sarcoma	1.06e-05	0.000388	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TLE1—sarcoma	1.06e-05	0.000388	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—NRAS—sarcoma	1.04e-05	0.000382	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ENO2—sarcoma	1.04e-05	0.000381	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—HBA1—sarcoma	1.03e-05	0.000379	CbGpPWpGaD
Trabectedin—SRC—Immune System—ATF1—sarcoma	1.03e-05	0.000378	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MMP2—sarcoma	1.01e-05	0.000371	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—KIT—sarcoma	1e-05	0.000369	CbGpPWpGaD
Trabectedin—SRC—Disease—PLCG1—sarcoma	9.99e-06	0.000367	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	9.89e-06	0.000364	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KIT—sarcoma	9.64e-06	0.000355	CbGpPWpGaD
Trabectedin—SRC—Disease—CXCR4—sarcoma	9.6e-06	0.000353	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CREB1—sarcoma	9.56e-06	0.000352	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—VEGFA—sarcoma	9.53e-06	0.00035	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—EGFR—sarcoma	9.48e-06	0.000348	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—NRAS—sarcoma	9.41e-06	0.000346	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CREB1—sarcoma	9.18e-06	0.000338	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—KRAS—sarcoma	8.95e-06	0.000329	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFC—sarcoma	8.9e-06	0.000327	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PLCG1—sarcoma	8.8e-06	0.000323	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—EGFR—sarcoma	8.58e-06	0.000315	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—KRAS—sarcoma	8.1e-06	0.000298	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MDM2—sarcoma	7.91e-06	0.000291	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—IL2—sarcoma	7.85e-06	0.000289	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ENO2—sarcoma	7.75e-06	0.000285	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CTNNB1—sarcoma	7.73e-06	0.000284	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—HBA1—sarcoma	7.7e-06	0.000283	CbGpPWpGaD
Trabectedin—SRC—Immune System—FOXO1—sarcoma	7.68e-06	0.000282	CbGpPWpGaD
Trabectedin—SRC—Immune System—PDGFRB—sarcoma	7.66e-06	0.000282	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HRAS—sarcoma	7.61e-06	0.00028	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—MDM2—sarcoma	7.6e-06	0.000279	CbGpPWpGaD
Trabectedin—SRC—Immune System—PDGFRA—sarcoma	7.54e-06	0.000277	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FLT1—sarcoma	7.12e-06	0.000262	CbGpPWpGaD
Trabectedin—SRC—Disease—FOXO1—sarcoma	7.09e-06	0.000261	CbGpPWpGaD
Trabectedin—SRC—Disease—PDGFRB—sarcoma	7.08e-06	0.00026	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PLCG1—sarcoma	7e-06	0.000257	CbGpPWpGaD
Trabectedin—SRC—Disease—PDGFRA—sarcoma	6.97e-06	0.000256	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—HRAS—sarcoma	6.89e-06	0.000253	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—JUN—sarcoma	6.88e-06	0.000253	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CTNNB1—sarcoma	6.82e-06	0.000251	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—VEGFA—sarcoma	6.8e-06	0.00025	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCR4—sarcoma	6.72e-06	0.000247	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NRAS—sarcoma	6.72e-06	0.000247	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—VEGFA—sarcoma	6.67e-06	0.000245	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ATF1—sarcoma	6.65e-06	0.000244	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NRAS—sarcoma	6.59e-06	0.000242	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PLCG1—sarcoma	6.57e-06	0.000242	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—sarcoma	6.12e-06	0.000225	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ENO2—sarcoma	5.98e-06	0.00022	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—HBA1—sarcoma	5.94e-06	0.000218	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—NRAS—sarcoma	5.93e-06	0.000218	CbGpPWpGaD
Trabectedin—SRC—Immune System—KIT—sarcoma	5.85e-06	0.000215	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—KRAS—sarcoma	5.78e-06	0.000213	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—NRAS—sarcoma	5.7e-06	0.000209	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—KRAS—sarcoma	5.67e-06	0.000209	CbGpPWpGaD
Trabectedin—SRC—Immune System—CREB1—sarcoma	5.57e-06	0.000205	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ENO2—sarcoma	5.5e-06	0.000202	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—HBA1—sarcoma	5.46e-06	0.000201	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ENO2—sarcoma	5.45e-06	0.0002	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—HBA1—sarcoma	5.42e-06	0.000199	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—sarcoma	5.41e-06	0.000199	CbGpPWpGaD
Trabectedin—SRC—Disease—KIT—sarcoma	5.4e-06	0.000199	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IGF1R—sarcoma	5.21e-06	0.000192	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—sarcoma	5.19e-06	0.000191	CbGpPWpGaD
Trabectedin—SRC—Disease—CREB1—sarcoma	5.14e-06	0.000189	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—KRAS—sarcoma	5.11e-06	0.000188	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PLCG1—sarcoma	5.07e-06	0.000186	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—sarcoma	5.04e-06	0.000185	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FOXO1—sarcoma	4.96e-06	0.000183	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PDGFRB—sarcoma	4.95e-06	0.000182	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—sarcoma	4.91e-06	0.000181	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KRAS—sarcoma	4.9e-06	0.00018	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PDGFRA—sarcoma	4.88e-06	0.000179	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—sarcoma	4.82e-06	0.000177	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PLCG1—sarcoma	4.66e-06	0.000172	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PLCG1—sarcoma	4.62e-06	0.00017	CbGpPWpGaD
Trabectedin—SRC—Immune System—MDM2—sarcoma	4.61e-06	0.000169	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—sarcoma	4.34e-06	0.00016	CbGpPWpGaD
Trabectedin—SRC—Disease—MDM2—sarcoma	4.25e-06	0.000156	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—sarcoma	4.17e-06	0.000153	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL2—sarcoma	4.12e-06	0.000151	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KDR—sarcoma	4.11e-06	0.000151	CbGpPWpGaD
Trabectedin—SRC—Immune System—JUN—sarcoma	4e-06	0.000147	CbGpPWpGaD
Trabectedin—SRC—Immune System—CTNNB1—sarcoma	3.97e-06	0.000146	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KIT—sarcoma	3.78e-06	0.000139	CbGpPWpGaD
Trabectedin—SRC—Disease—CTNNB1—sarcoma	3.67e-06	0.000135	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CREB1—sarcoma	3.6e-06	0.000132	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ENO2—sarcoma	3.59e-06	0.000132	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HBA1—sarcoma	3.57e-06	0.000131	CbGpPWpGaD
Trabectedin—SRC—Immune System—NRAS—sarcoma	3.46e-06	0.000127	CbGpPWpGaD
Trabectedin—SRC—Disease—NRAS—sarcoma	3.19e-06	0.000117	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—sarcoma	3.15e-06	0.000116	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PLCG1—sarcoma	3.05e-06	0.000112	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MDM2—sarcoma	2.98e-06	0.00011	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—sarcoma	2.97e-06	0.000109	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—sarcoma	2.97e-06	0.000109	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—sarcoma	2.91e-06	0.000107	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—sarcoma	2.75e-06	0.000101	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL2—sarcoma	2.66e-06	9.79e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—sarcoma	2.59e-06	9.54e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JUN—sarcoma	2.59e-06	9.52e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CTNNB1—sarcoma	2.57e-06	9.45e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—sarcoma	2.53e-06	9.3e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—sarcoma	2.33e-06	8.58e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—sarcoma	2.26e-06	8.32e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NRAS—sarcoma	2.23e-06	8.22e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—sarcoma	2.08e-06	7.65e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—sarcoma	2.04e-06	7.48e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—sarcoma	1.92e-06	7.07e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—sarcoma	1.71e-06	6.28e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—sarcoma	1.63e-06	6.01e-05	CbGpPWpGaD
